Literature DB >> 3600822

Unbound plasma concentrations, total plasma concentrations, and red blood cell concentrations of thioridazine and its main metabolites: an in vitro study.

G Nyberg, E Mårtensson.   

Abstract

The relationships between, on the one hand, the unbound plasma concentrations of thioridazine and thioridazine metabolites and, on the other, the total plasma concentrations and the red blood cell concentrations were studied in vitro. The relationships between the unbound and total plasma concentrations were curvilinear, while those between the unbound concentrations and the red blood cell concentrations within a broad range were closer to rectilinear. Profound changes were seen in the relationship between unbound and total plasma concentrations at varying concentrations of alpha 1-acid glycoprotein, while the rectilinear relationship between the unbound plasma concentrations and the red blood cell concentrations remained essentially unchanged.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600822     DOI: 10.1007/bf00165564

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Concentrations of thioridazine and thioridazine metabolites in erythrocytes.

Authors:  C Svensson; G Nyberg; R Axelsson; E Mårtensson
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

3.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

4.  Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.

Authors:  E Mårtensson; G Nyberg; R Axelsson; K Serck-Hansen
Journal:  Curr Ther Res Clin Exp       Date:  1975-11

5.  Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.

Authors:  G Nyberg; E Mårtensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

6.  Plasma and red cell levels of thioridazine and clinical response in schizophrenia.

Authors:  R C Smith; R Baumgartner; G K Ravichandran; A Shvartsburd; J C Schoolar; P Allen; R Johnson
Journal:  Psychiatry Res       Date:  1984-08       Impact factor: 3.222

7.  Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.

Authors:  D B Bylund
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

8.  Uptake and/or binding of tricyclic antidepressants in human red cells.

Authors:  J I Javaid; J M Davis; M Maiorano
Journal:  Life Sci       Date:  1985-05-06       Impact factor: 5.037

9.  Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia.

Authors:  R Casper; D L Garver; H Dekirmenjian; S Chang; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1980-03

10.  Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.

Authors:  C D Kilts; D L Knight; R B Mailman; E Widerlöv; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.